{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:51:24Z","timestamp":1793746284230,"version":"4.6.1"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"Chinese National Natural Science Foundation Grants","doi-asserted-by":"crossref","award":["81401670"],"award-info":[{"award-number":["81401670"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"China Mega-Project for Infectious Disease","award":["2011ZX10004-101"],"award-info":[{"award-number":["2011ZX10004-101"]}]},{"name":"China Mega-Project for Infectious Disease","award":["2012ZX10004215"],"award-info":[{"award-number":["2012ZX10004215"]}]},{"name":"the SKLID Development Grant","award":["2012SKLID102"],"award-info":[{"award-number":["2012SKLID102"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Poverty"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s40249-016-0143-8","type":"journal-article","created":{"date-parts":[[2016,5,10]],"date-time":"2016-05-10T10:08:20Z","timestamp":1462874900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":137,"title":["Epidemiological characteristics of human prion diseases"],"prefix":"10.1186","volume":"5","author":[{"given":"Cao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ping","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,2]]},"reference":[{"issue":"3","key":"143_CR1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1750-3639.1998.tb00171.x","volume":"8","author":"SB Prusiner","year":"1998","unstructured":"Prusiner SB. The prion diseases. Brain Pathol. 1998;8(3):499\u2013513.","journal-title":"Brain Pathol"},{"key":"143_CR2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000077051","volume":"11","author":"R Knight","year":"2004","unstructured":"Knight R, Brazier M, Collins SJ. Human prion diseases: cause, clinical and diagnostic aspects. Contrib Microbiol. 2004;11:72\u201397.","journal-title":"Contrib Microbiol"},{"issue":"23","key":"143_CR3","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"SB Prusiner","year":"1998","unstructured":"Prusiner SB. Prions. Proc Natl Acad Sci U S A. 1998;95(23):13363\u201383.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5619","key":"143_CR4","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1126\/science.1083320","volume":"300","author":"S Mead","year":"2003","unstructured":"Mead S, Stumpf MP, Whitfield J, Beck JA, Poulter M, Campbell T, et al. Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science. 2003;300(5619):640\u20133. doi: 10.1126\/science.1083320 .","journal-title":"Science"},{"key":"143_CR5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.neuro.24.1.519","volume":"24","author":"J Collinge","year":"2001","unstructured":"Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci. 2001;24:519\u201350. doi: 10.1146\/annurev.neuro.24.1.519 .","journal-title":"Annu Rev Neurosci"},{"issue":"7","key":"143_CR6","first-page":"1059","volume":"17","author":"C Ryou","year":"2007","unstructured":"Ryou C. Prions and prion diseases: fundamentals and mechanistic details. J Microbiol Biotechnol. 2007;17(7):1059\u201370.","journal-title":"J Microbiol Biotechnol"},{"issue":"6","key":"143_CR7","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/ana.410390613","volume":"39","author":"P Parchi","year":"1996","unstructured":"Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol. 1996;39(6):767\u201378. doi: 10.1002\/ana.410390613 .","journal-title":"Ann Neurol"},{"issue":"9100","key":"143_CR8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(05)78358-6","volume":"351","author":"S Shibuya","year":"1998","unstructured":"Shibuya S, Higuchi J, Shin RW, Tateishi J, Kitamoto T. Protective prion protein polymorphisms against sporadic Creutzfeldt-Jakob disease. Lancet. 1998;351(9100):419. doi: 10.1016\/S0140-6736(05)78358-6 .","journal-title":"Lancet"},{"issue":"2","key":"143_CR9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","volume":"46","author":"P Parchi","year":"1999","unstructured":"Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 1999;46(2):224\u201333.","journal-title":"Ann Neurol"},{"issue":"6","key":"143_CR10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/ana.20127","volume":"55","author":"MW Head","year":"2004","unstructured":"Head MW, Bunn TJ, Bishop MT, McLoughlin V, Lowrie S, McKimmie CS, et al. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991\u20132002. Ann Neurol. 2004;55(6):851\u20139. doi: 10.1002\/ana.20127 .","journal-title":"Ann Neurol"},{"issue":"3","key":"143_CR11","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1750-3639.2008.00187.x","volume":"19","author":"P Parchi","year":"2009","unstructured":"Parchi P, Notari S, Weber P, Schimmel H, Budka H, Ferrer I, et al. Inter-laboratory assessment of PrPSc typing in creutzfeldt-jakob disease: a Western blot study within the NeuroPrion Consortium. Brain Pathol. 2009;19(3):384\u201391. doi: 10.1111\/j.1750-3639.2008.00187.x .","journal-title":"Brain Pathol"},{"issue":"5","key":"143_CR12","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00401-009-0585-1","volume":"118","author":"P Parchi","year":"2009","unstructured":"Parchi P, Strammiello R, Notari S, Giese A, Langeveld JP, Ladogana A, et al. Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol. 2009;118(5):659\u201371. doi: 10.1007\/s00401-009-0585-1 .","journal-title":"Acta Neuropathol"},{"issue":"Suppl 1","key":"143_CR13","doi-asserted-by":"crossref","first-page":"i36","DOI":"10.1136\/jnnp.2004.036137","volume":"75","author":"RS Knight","year":"2004","unstructured":"Knight RS, Will RG. Prion diseases. J Neurol Neurosurg Psychiatry. 2004;75 Suppl 1:i36\u201342.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"143_CR14","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/brain\/awm063","volume":"130","author":"U Heinemann","year":"2007","unstructured":"Heinemann U, Krasnianski A, Meissner B, Varges D, Kallenberg K, Schulz-Schaeffer WJ, et al. Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain. 2007;130(5):1350\u20139.","journal-title":"Brain"},{"issue":"8\u20139","key":"143_CR15","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.neurol.2009.04.006","volume":"165","author":"JP Brandel","year":"2009","unstructured":"Brandel JP, Salomon D, Capek I, Vaillant V, Alperovitch A. Epidemiological surveillance of Creutzfeldt-Jakob in France. Rev Neurol (Paris). 2009;165(8\u20139):684\u201393.","journal-title":"Rev Neurol (Paris)"},{"issue":"10","key":"143_CR16","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1093\/brain\/awq216","volume":"133","author":"I Nozaki","year":"2010","unstructured":"Nozaki I, Hamaguchi T, Sanjo N, Noguchi-Shinohara M, Sakai K, Nakamura Y, et al. Prospective 10-year surveillance of human prion diseases in Japan. Brain. 2010;133(10):3043\u201357.","journal-title":"Brain"},{"issue":"3\u20134","key":"143_CR17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000331907","volume":"37","author":"C Begue","year":"2011","unstructured":"Begue C, Martinetto H, Schultz M, Rojas E, Romero C, D\u2019Giano C, et al. Creutzfeldt-Jakob disease surveillance in Argentina, 1997\u20132008. Neuroepidemiology. 2011;37(3\u20134):193\u2013202.","journal-title":"Neuroepidemiology"},{"issue":"1","key":"143_CR18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/jmv.24004","volume":"87","author":"J Lee","year":"2015","unstructured":"Lee J, Hyeon JW, Kim SY, Hwang KJ, Ju YR, Ryou C. Review: Laboratory diagnosis and surveillance of Creutzfeldt-Jakob disease. J Med Virol. 2015;87(1):175\u201386. doi: 10.1002\/jmv.24004 .","journal-title":"J Med Virol"},{"key":"143_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02866081","volume":"57","author":"HG Creutzfeldt","year":"1920","unstructured":"Creutzfeldt HG. Uber eine eigenartige herdformige Erkrankung des Zentralnervensystems. Z Neurol U Psychiatr. 1920;57:1\u201318.","journal-title":"Z Neurol U Psychiatr"},{"key":"143_CR20","first-page":"132","volume":"70","author":"A Jakob","year":"1921","unstructured":"Jakob A. Uber eine eigenartige Erkrankung des Zentral-nervensystems mit bemerkenswertem anatomischem Befunde (spastische pseudosklerotische Encephalomyelopathie mit disseminierten Degenerationsherden). Dtsch Z Nervenheilk. 1921;70:132\u201346.","journal-title":"Dtsch Z Nervenheilk"},{"key":"143_CR21","volume-title":"WHO manual for surveillance of human transmissible spongiform encephalopathies including variant Creutzfeldt-Jakob disease. WHO Communicable Disease Surveillance and Response","author":"WHO","year":"2003","unstructured":"WHO. WHO manual for surveillance of human transmissible spongiform encephalopathies including variant Creutzfeldt-Jakob disease. WHO Communicable Disease Surveillance and Response. 2003."},{"issue":"8","key":"143_CR22","doi-asserted-by":"crossref","first-page":"e24231","DOI":"10.1371\/journal.pone.0024231","volume":"6","author":"C Gao","year":"2011","unstructured":"Gao C, Shi Q, Tian C, Chen C, Han J, Zhou W, et al. The epidemiological, clinical, and laboratory features of sporadic Creutzfeldt-Jakob disease patients in China: surveillance data from 2006 to 2010. PLoS One. 2011;6(8):e24231.","journal-title":"PLoS One"},{"key":"143_CR23","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1743-422X-8-559","volume":"8","author":"M Imran","year":"2011","unstructured":"Imran M, Mahmood S. An overview of human prion diseases. Virol J. 2011;8:559. doi: 10.1186\/1743-422\u00d7-8-559 .","journal-title":"Virol J"},{"issue":"5","key":"143_CR24","doi-asserted-by":"crossref","first-page":"e62553","DOI":"10.1371\/journal.pone.0062553","volume":"8","author":"C Chen","year":"2013","unstructured":"Chen C, Wang JC, Shi Q, Zhou W, Zhang XM, Zhang J, et al. Analyses of the survival time and the influencing factors of chinese patients with prion diseases based on the surveillance data from 2008\u20132011. PLoS One. 2013;8(5):e62553.","journal-title":"PLoS One"},{"issue":"Pt 9","key":"143_CR25","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/brain\/awl159","volume":"129","author":"SJ Collins","year":"2006","unstructured":"Collins SJ, Sanchez-Juan P, Masters CL, Klug GM, Van Duijn C, Poleggi A, et al. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain. 2006;129(Pt 9):2278\u201387.","journal-title":"Brain"},{"issue":"4","key":"143_CR26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2188\/jea.JE20100085","volume":"21","author":"K Nagoshi","year":"2011","unstructured":"Nagoshi K, Sadakane A, Nakamura Y, Yamada M, Mizusawa H. Duration of prion disease is longer in Japan than in other countries. J Epidemiol. 2011;21(4):255\u201362.","journal-title":"J Epidemiol"},{"issue":"9","key":"143_CR27","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.WNL.0000160117.56690.B2","volume":"64","author":"A Ladogana","year":"2005","unstructured":"Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S, et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology. 2005;64(9):1586\u201391. doi: 10.1212\/01.WNL.0000160117.56690.B2 .","journal-title":"Neurology"},{"issue":"4","key":"143_CR28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2188\/jea.17.133","volume":"17","author":"Y Doi","year":"2007","unstructured":"Doi Y, Yokoyama T, Sakai M, Nakamura Y. Creutzfeldt-Jakob disease mortality in Japan, 1979\u20132004: analysis of national death certificate data. J Epidemiol. 2007;17(4):133\u20139.","journal-title":"J Epidemiol"},{"issue":"4","key":"143_CR29","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/19336896.2015.1075115","volume":"9","author":"Q Shi","year":"2015","unstructured":"Shi Q, Zhang XC, Zhou W, Xiao K, Chen C, Zhang HY, et al. Analysis of the advantage features of Beijing surveillance network for Creutzfeldt-Jakob disease. Prion. 2015;9(4):304\u201314. doi: 10.1080\/19336896.2015.1075115 .","journal-title":"Prion"},{"issue":"1","key":"143_CR30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008521","volume":"5","author":"RC Holman","year":"2010","unstructured":"Holman RC, Belay ED, Christensen KY, Maddox RA, Minino AM, Folkema AM, et al. Human prion diseases in the United States. PLoS One. 2010;5(1), e8521. doi: 10.1371\/journal.pone.0008521 .","journal-title":"PLoS One"},{"issue":"3","key":"143_CR31","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1212\/01.wnl.0000196473.46805.61","volume":"66","author":"RA Maddox","year":"2006","unstructured":"Maddox RA, Holman RC, Belay ED, Cheek JE, Yorita KL, Schonberger LB. Creutzfeldt-Jakob disease among American Indians and Alaska Natives in the United States. Neurology. 2006;66(3):439\u201341. doi: 10.1212\/01.wnl.0000196473.46805.61 .","journal-title":"Neurology"},{"issue":"4","key":"143_CR32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/GIM.0b013e3181cd7374","volume":"12","author":"JA Mastrianni","year":"2010","unstructured":"Mastrianni JA. The genetics of prion diseases. Genet Med. 2010;12(4):187\u201395. doi: 10.1097\/GIM.0b013e3181cd7374 .","journal-title":"Genet Med"},{"issue":"6\u20137","key":"143_CR33","first-page":"633","volume":"157","author":"E Group","year":"2001","unstructured":"Group E. Genetic epidemiology of Creutzfeldt-Jakob disease in Europe. Rev Neurol (Paris). 2001;157(6\u20137):633\u20137.","journal-title":"Rev Neurol (Paris)"},{"issue":"2","key":"143_CR34","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00439-005-0020-1","volume":"118","author":"GG Kovacs","year":"2005","unstructured":"Kovacs GG, Puopolo M, Ladogana A, Pocchiari M, Budka H, Van Duijn C, et al. Genetic prion disease: the EUROCJD experience. Hum Genet. 2005;118(2):166\u201374. doi: 10.1007\/s00439-005-0020-1 .","journal-title":"Hum Genet"},{"issue":"9","key":"143_CR35","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1212\/01.WNL.0000160118.26865.11","volume":"64","author":"A Ladogana","year":"2005","unstructured":"Ladogana A, Puopolo M, Poleggi A, Almonti S, Mellina V, Equestre M, et al. High incidence of genetic human transmissible spongiform encephalopathies in Italy. Neurology. 2005;64(9):1592\u20137. doi: 10.1212\/01.WNL.0000160118.26865.11 .","journal-title":"Neurology"},{"issue":"10","key":"143_CR36","volume":"10","author":"Q Shi","year":"2015","unstructured":"Shi Q, Zhou W, Chen C, Zhang BY, Xiao K, Zhang XC, et al. The Features of Genetic Prion Diseases Based on Chinese Surveillance Program. PLoS One. 2015;10(10):e0139552. doi: 10.1371\/journal.pone.0139552 .","journal-title":"PLoS One"},{"issue":"3","key":"143_CR37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3346\/jkms.1998.13.3.234","volume":"13","author":"BH Jeong","year":"1998","unstructured":"Jeong BH, Ju WK, Huh K, Lee EA, Choi IS, Im JH, et al. Molecular analysis of prion protein gene (PRNP) in Korean patients with Creutzfeldt-Jakob disease. J Korean Med Sci. 1998;13(3):234\u201340.","journal-title":"J Korean Med Sci"},{"key":"143_CR38","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1471-2334-9-132","volume":"9","author":"BY Choi","year":"2009","unstructured":"Choi BY, Kim SY, Seo SY, An SS, Kim S, Park SE, et al. Mutations at codons 178, 200\u2013129, and 232 contributed to the inherited prion diseases in Korean patients. BMC Infect Dis. 2009;9:132. doi: 10.1186\/1471-2334-9-132 .","journal-title":"BMC Infect Dis"},{"issue":"6","key":"143_CR39","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2990.2010.01094.x","volume":"36","author":"BH Jeong","year":"2010","unstructured":"Jeong BH, Jeon YC, Lee YJ, Cho HJ, Park SJ, Chung DI, et al. Creutzfeldt-Jakob disease with the V203I mutation and M129V polymorphism of the prion protein gene (PRNP) and a 17\u00a0kDa prion protein fragment. Neuropathol Appl Neurobiol. 2010;36(6):558\u201363. doi: 10.1111\/j.1365-2990.2010.01094.x .","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"7","key":"143_CR40","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3346\/jkms.2010.25.7.1097","volume":"25","author":"TI Yang","year":"2010","unstructured":"Yang TI, Jung DS, Ahn BY, Jeong BH, Cho HJ, Kim YS, et al. Familial Creutzfeldt-Jakob disease with V180I mutation. J Korean Med Sci. 2010;25(7):1097\u2013100. doi: 10.3346\/jkms.2010.25.7.1097 .","journal-title":"J Korean Med Sci"},{"issue":"4","key":"143_CR41","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4161\/pri.20195","volume":"6","author":"S Moe Lee","year":"2012","unstructured":"Moe Lee S, Ran Ju Y, Choi BY, Wook Hyeon J, Sun Park J, Kyeong Kim C, et al. Genotype patterns and characteristics of PRNP in the Korean population. Prion. 2012;6(4):375\u201382. doi: 10.4161\/pri.20195 .","journal-title":"Prion"},{"issue":"1","key":"143_CR42","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jocn.2012.01.044","volume":"20","author":"MJ Yeo","year":"2013","unstructured":"Yeo MJ, Lee SH, Lee SY, Jeon YC, Park SJ, Cho HJ, et al. Familial Creutzfeldt-Jakob disease with a mutation at codon 180 presenting with an atypical phenotype. J Clin Neurosci. 2013;20(1):180\u20132. doi: 10.1016\/j.jocn.2012.01.044 .","journal-title":"J Clin Neurosci"},{"issue":"5","key":"143_CR43","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3346\/jkms.2014.29.5.623","volume":"29","author":"BH Jeong","year":"2014","unstructured":"Jeong BH, Kim YS. Genetic studies in human prion diseases. J Korean Med Sci. 2014;29(5):623\u201332. doi: 10.3346\/jkms.2014.29.5.623 .","journal-title":"J Korean Med Sci"},{"issue":"9165","key":"143_CR44","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(99)01342-2","volume":"353","author":"A Alperovitch","year":"1999","unstructured":"Alperovitch A, Zerr I, Pocchiari M, Mitrova E, De Pedro CJ, Hegyi I, et al. Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet. 1999;353(9165):1673\u20134.","journal-title":"Lancet"},{"issue":"6","key":"143_CR45","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1212\/WNL.55.6.811","volume":"55","author":"I Zerr","year":"2000","unstructured":"Zerr I, Pocchiari M, Collins S, Brandel JP, De Pedro CJ, Knight RS, et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2000;55(6):811\u20135.","journal-title":"Neurology"},{"issue":"Pt 10","key":"143_CR46","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1093\/brain\/awh249","volume":"127","author":"M Pocchiari","year":"2004","unstructured":"Pocchiari M, Puopolo M, Croes EA, Budka H, Gelpi E, Collins S, et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain. 2004;127(Pt 10):2348\u201359. doi: 10.1093\/brain\/awh249 .","journal-title":"Brain"},{"issue":"3\u20134","key":"143_CR47","first-page":"153","volume":"47","author":"C Vital","year":"1999","unstructured":"Vital C, Gray F, Vital A, Ferrer X, Julien J. Prion disease with octapeptide repeat insertion. Clin Exp Pathol. 1999;47(3\u20134):153\u20139.","journal-title":"Clin Exp Pathol"},{"issue":"11","key":"143_CR48","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00415-002-0896-9","volume":"249","author":"GG Kovacs","year":"2002","unstructured":"Kovacs GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, Budka H. Mutations of the prion protein gene phenotypic spectrum. J Neurol. 2002;249(11):1567\u201382. doi: 10.1007\/s00415-002-0896-9 .","journal-title":"J Neurol"},{"issue":"4","key":"143_CR49","first-page":"471","volume":"25","author":"Q Shi","year":"2012","unstructured":"Shi Q, Chen C, Gao C, Tian C, Zhou W, Zhang B, et al. Clinical and familial characteristics of ten chinese patients with fatal family insomnia. Biomed Environ Sci. 2012;25(4):471\u20135.","journal-title":"Biomed Environ Sci"},{"issue":"4","key":"143_CR50","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/0891988710383576","volume":"23","author":"K Brown","year":"2010","unstructured":"Brown K, Mastrianni JA. The prion diseases. J Geriatr Psychiatry Neurol. 2010;23(4):277\u201398. doi: 10.1177\/0891988710383576 .","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"143_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/128_2011_157","volume":"305","author":"S Lloyd","year":"2011","unstructured":"Lloyd S, Mead S, Collinge J. Genetics of prion disease. Top Curr Chem. 2011;305:1\u201322. doi: 10.1007\/128_2011_157 .","journal-title":"Top Curr Chem"},{"issue":"6","key":"143_CR52","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ana.410430618","volume":"43","author":"S Shibuya","year":"1998","unstructured":"Shibuya S, Higuchi J, Shin RW, Tateishi J, Kitamoto T. Codon 219 Lys allele of PRNP is not found in sporadic Creutzfeldt-Jakob disease. Ann Neurol. 1998;43(6):826\u20138. doi: 10.1002\/ana.410430618 .","journal-title":"Ann Neurol"},{"issue":"4","key":"143_CR53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036333","volume":"7","author":"C Jansen","year":"2012","unstructured":"Jansen C, Parchi P, Capellari S, Ibrahim-Verbaas CA, Schuur M, Strammiello R, et al. Human prion diseases in the Netherlands (1998\u20132009): clinical, genetic and molecular aspects. PLoS One. 2012;7(4), e36333. doi: 10.1371\/journal.pone.0036333 .","journal-title":"PLoS One"},{"issue":"12","key":"143_CR54","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1212\/WNL.44.12.2347","volume":"44","author":"JL Laplanche","year":"1994","unstructured":"Laplanche JL, Delasnerie-Laupretre N, Brandel JP, Chatelain J, Beaudry P, Alperovitch A, et al. Molecular genetics of prion diseases in France. French Research Group on Epidemiology of Human Spongiform Encephalopathies. Neurology. 1994;44(12):2347\u201351.","journal-title":"Neurology"},{"issue":"6333","key":"143_CR55","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/352340a0","volume":"352","author":"MS Palmer","year":"1991","unstructured":"Palmer MS, Dryden AJ, Hughes JT, Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature. 1991;352(6333):340\u20132. doi: 10.1038\/352340a0 .","journal-title":"Nature"},{"issue":"1","key":"143_CR56","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0272-2712(02)00068-9","volume":"23","author":"HJ Ward","year":"2003","unstructured":"Ward HJ, Head MW, Will RG, Ironside JW. Variant Creutzfeldt-Jakob disease. Clin Lab Med. 2003;23(1):87\u2013108.","journal-title":"Clin Lab Med"},{"issue":"4","key":"143_CR57","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10048-005-0016-y","volume":"6","author":"BH Jeong","year":"2005","unstructured":"Jeong BH, Lee KH, Kim NH, Jin JK, Kim JI, Carp RI, et al. Association of sporadic Creutzfeldt-Jakob disease with homozygous genotypes at PRNP codons 129 and 219 in the Korean population. Neurogenetics. 2005;6(4):229\u201332. doi: 10.1007\/s10048-005-0016-y .","journal-title":"Neurogenetics"},{"issue":"6","key":"143_CR58","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10038-004-0150-7","volume":"49","author":"BH Jeong","year":"2004","unstructured":"Jeong BH, Nam JH, Lee YJ, Lee KH, Jang MK, Carp RI, et al. Polymorphisms of the prion protein gene (PRNP) in a Korean population. J Hum Genet. 2004;49(6):319\u201324. doi: 10.1007\/s10038-004-0150-7 .","journal-title":"J Hum Genet"},{"issue":"4","key":"143_CR59","first-page":"888","volume":"58","author":"R Petraroli","year":"1996","unstructured":"Petraroli R, Pocchiari M. Codon 219 polymorphism of PRNP in healthy Caucasians and Creutzfeldt-Jakob disease patients. Am J Hum Genet. 1996;58(4):888\u20139.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"143_CR60","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00401-010-0760-4","volume":"121","author":"S Capellari","year":"2011","unstructured":"Capellari S, Strammiello R, Saverioni D, Kretzschmar H, Parchi P. Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis. Acta Neuropathol. 2011;121(1):21\u201337. doi: 10.1007\/s00401-010-0760-4 .","journal-title":"Acta Neuropathol"},{"key":"143_CR61","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/bmb\/66.1.213","volume":"66","author":"P Gambetti","year":"2003","unstructured":"Gambetti P, Kong Q, Zou W, Parchi P, Chen SG. Sporadic and familial CJD: classification and characterisation. Br Med Bull. 2003;66:213\u201339.","journal-title":"Br Med Bull"},{"issue":"12","key":"143_CR62","first-page":"692","volume":"290","author":"P Duffy","year":"1974","unstructured":"Duffy P, Wolf J, Collins G, DeVoe AG, Streeten B, Cowen D. Letter: Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med. 1974;290(12):692\u20133.","journal-title":"N Engl J Med"},{"issue":"8009","key":"143_CR63","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0140-6736(77)91958-4","volume":"1","author":"C Bernoulli","year":"1977","unstructured":"Bernoulli C, Siegfried J, Baumgartner G, Regli F, Rabinowicz T, Gajdusek DC, et al. Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet. 1977;1(8009):478\u20139.","journal-title":"Lancet"},{"issue":"3","key":"143_CR64","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/jnnp.45.3.235","volume":"45","author":"RG Will","year":"1982","unstructured":"Will RG, Matthews WB. Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. 1982;45(3):235\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8859","key":"143_CR65","first-page":"1543","volume":"341","author":"DM Taylor","year":"1993","unstructured":"Taylor DM, Bell JE. Prevention of iatrogenic transmission of Creutzfeldt-Jakob disease. Lancet. 1993;341(8859):1543\u20134.","journal-title":"Lancet"},{"issue":"4","key":"143_CR66","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0764-4469(97)82774-6","volume":"320","author":"KH El Hachimi","year":"1997","unstructured":"El Hachimi KH, Chaunu MP, Cervenakova L, Brown P, Foncin JF. Putative neurosurgical transmission of Creutzfeldt-Jakob disease with analysis of donor and recipient: agent strains. C R Acad Sci III. 1997;320(4):319\u201328.","journal-title":"C R Acad Sci III"},{"issue":"5","key":"143_CR67","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1440-1789.2009.01023.x","volume":"29","author":"T Hamaguchi","year":"2009","unstructured":"Hamaguchi T, Noguchi-Shinohara M, Nozaki I, Nakamura Y, Sato T, Kitamoto T, et al. The risk of iatrogenic Creutzfeldt-Jakob disease through medical and surgical procedures. Neuropathology. 2009;29(5):625\u201331. doi: 10.1111\/j.1440-1789.2009.01023.x .","journal-title":"Neuropathology"},{"issue":"6","key":"143_CR68","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3201\/eid1806.120116","volume":"18","author":"P Brown","year":"2012","unstructured":"Brown P, Brandel JP, Sato T, Nakamura Y, MacKenzie J, Will RG, et al. Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis. 2012;18(6):901\u20137. doi: 10.3201\/eid1806.120116 .","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"143_CR69","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3201\/eid1904.121504","volume":"19","author":"BS Appleby","year":"2013","unstructured":"Appleby BS, Lu M, Bizzi A, Phillips MD, Berri SM, Harbison MD, et al. Iatrogenic Creutzfeldt-Jakob disease from commercial cadaveric human growth hormone. Emerg Infect Dis. 2013;19(4):682\u20134. doi: 10.3201\/eid1904.121504 .","journal-title":"Emerg Infect Dis"},{"key":"143_CR70","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/bmb\/66.1.255","volume":"66","author":"RG Will","year":"2003","unstructured":"Will RG. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br Med Bull. 2003;66:255\u201365.","journal-title":"Br Med Bull"},{"issue":"4","key":"143_CR71","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1212\/01.wnl.0000266624.63387.4a","volume":"69","author":"M Noguchi-Shinohara","year":"2007","unstructured":"Noguchi-Shinohara M, Hamaguchi T, Kitamoto T, Sato T, Nakamura Y, Mizusawa H, et al. Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease. Neurology. 2007;69(4):360\u20137. doi: 10.1212\/01.wnl.0000266624.63387.4a .","journal-title":"Neurology"},{"issue":"5","key":"143_CR72","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1440-1789.2008.00987.x","volume":"29","author":"M Yamada","year":"2009","unstructured":"Yamada M, Noguchi-Shinohara M, Hamaguchi T, Nozaki I, Kitamoto T, Sato T, et al. Dura mater graft-associated Creutzfeldt-Jakob disease in Japan: clinicopathological and molecular characterization of the two distinct subtypes. Neuropathology. 2009;29(5):609\u201318. doi: 10.1111\/j.1440-1789.2008.00987.x .","journal-title":"Neuropathology"},{"issue":"9378","key":"143_CR73","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0140-6736(03)13867-6","volume":"362","author":"JP Brandel","year":"2003","unstructured":"Brandel JP, Preece M, Brown P, Croes E, Laplanche JL, Agid Y, et al. Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK. Lancet. 2003;362(9378):128\u201330. doi: 10.1016\/S0140-6736(03)13867-6 .","journal-title":"Lancet"},{"issue":"Pt 11","key":"143_CR74","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1093\/brain\/awv235","volume":"138","author":"P Rudge","year":"2015","unstructured":"Rudge P, Jaunmuktane Z, Adlard P, Bjurstrom N, Caine D, Lowe J, et al. Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40\u00a0years. Brain. 2015;138(Pt 11):3386\u201399. doi: 10.1093\/brain\/awv235 .","journal-title":"Brain"},{"issue":"9006","key":"143_CR75","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(96)91412-9","volume":"347","author":"RG Will","year":"1996","unstructured":"Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996;347(9006):921\u20135.","journal-title":"Lancet"},{"key":"143_CR76","unstructured":"Statistics NCRSUDaRLNCM. National CJD Research & Surveillance Unit Data and Reports Latest NCJDSRU CJD Monthly Statistics. [update in April 2015]. Available from: http:\/\/www.cjd.ed.ac.uk\/documents\/figs.pdf ."},{"issue":"4","key":"143_CR77","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4161\/pri.29237","volume":"8","author":"AB Diack","year":"2014","unstructured":"Diack AB, Head MW, McCutcheon S, Boyle A, Knight R, Ironside JW, et al. Variant CJD. 18\u00a0years of research and surveillance. Prion. 2014;8(4):286\u201395. doi: 10.4161\/pri.29237 .","journal-title":"Prion"},{"issue":"1","key":"143_CR78","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/ije\/dyh374","volume":"34","author":"M Chadeau-Hyam","year":"2005","unstructured":"Chadeau-Hyam M, Alperovitch A. Risk of variant Creutzfeldt-Jakob disease in France. Int J Epidemiol. 2005;34(1):46\u201352. doi: 10.1093\/ije\/dyh374 .","journal-title":"Int J Epidemiol"},{"issue":"4","key":"143_CR79","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.tracli.2013.02.029","volume":"20","author":"JP Brandel","year":"2013","unstructured":"Brandel JP, Peckeu L, Haik S. The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide. Transfus Clin Biol. 2013;20(4):395\u20137. doi: 10.1016\/j.tracli.2013.02.029 .","journal-title":"Transfus Clin Biol"},{"issue":"3","key":"143_CR80","first-page":"296","volume":"7","author":"R Kay","year":"2001","unstructured":"Kay R, Lau WY, Ng HK, Chan YL, Lyon DJ, Van Hasselt CA. Variant Creutzfeldt-Jakob disease in Hong Kong. Hong Kong medical journal\u2009=\u2009Xianggang yi xue za zhi\/Hong Kong Academy of Medicine. 2001;7(3):296\u20138.","journal-title":"Hong Kong medical journal\u2009=\u2009Xianggang yi xue za zhi\/Hong Kong Academy of Medicine"},{"issue":"9513","key":"143_CR81","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0140-6736(06)68344-X","volume":"367","author":"M Yamada","year":"2006","unstructured":"Yamada M, Variant Cjd Working Group C-JDSCJ. The first Japanese case of variant Creutzfeldt-Jakob disease showing periodic electroencephalogram. Lancet. 2006;367(9513):874. doi: 10.1016\/S0140-6736(06)68344-X .","journal-title":"Lancet"},{"issue":"6","key":"143_CR82","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1440-1789.2009.01006.x","volume":"29","author":"A Shinde","year":"2009","unstructured":"Shinde A, Kunieda T, Kinoshita Y, Wate R, Nakano S, Ito H, et al. The first Japanese patient with variant Creutzfeldt-Jakob disease (vCJD). Neuropathology. 2009;29(6):713\u20139. doi: 10.1111\/j.1440-1789.2009.01006.x .","journal-title":"Neuropathology"},{"issue":"6","key":"143_CR83","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1440-1819.2010.02151.x","volume":"64","author":"CW Yang","year":"2010","unstructured":"Yang CW, Fuh JL, Wang SJ, Lirng JF, Yang CC, Cheng SJ. Probable variant Creutzfeldt-Jakob disease in Asia: a case report from Taiwan and review of two prior cases. Psychiatry Clin Neurosci. 2010;64(6):652\u20138.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"3","key":"143_CR84","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ana.21583","volume":"65","author":"JP Brandel","year":"2009","unstructured":"Brandel JP, Heath CA, Head MW, Levavasseur E, Knight R, Laplanche JL, et al. Variant Creutzfeldt-Jakob disease in France and the United Kingdom: Evidence for the same agent strain. Ann Neurol. 2009;65(3):249\u201356. doi: 10.1002\/ana.21583 .","journal-title":"Ann Neurol"},{"issue":"10","key":"143_CR85","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3201\/eid1810.120792","volume":"18","author":"AB Diack","year":"2012","unstructured":"Diack AB, Ritchie D, Bishop M, Pinion V, Brandel JP, Haik S, et al. Constant transmission properties of variant Creutzfeldt-Jakob disease in 5 countries. Emerg Infect Dis. 2012;18(10):1574\u20139. doi: 10.3201\/eid1810.120792 .","journal-title":"Emerg Infect Dis"},{"issue":"9552","key":"143_CR86","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/S0140-6736(06)69835-8","volume":"368","author":"SJ Wroe","year":"2006","unstructured":"Wroe SJ, Pal S, Siddique D, Hyare H, Macfarlane R, Joiner S, et al. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet. 2006;368(9552):2061\u20137. doi: 10.1016\/S0140-6736(06)69835-8 .","journal-title":"Lancet"},{"issue":"28","key":"143_CR87","doi-asserted-by":"crossref","first-page":"10759","DOI":"10.1073\/pnas.0604292103","volume":"103","author":"EA Asante","year":"2006","unstructured":"Asante EA, Linehan JM, Gowland I, Joiner S, Fox K, Cooper S, et al. Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice. Proc Natl Acad Sci U S A. 2006;103(28):10759\u201364. doi: 10.1073\/pnas.0604292103 .","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5702","key":"143_CR88","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1126\/science.1103932","volume":"306","author":"JD Wadsworth","year":"2004","unstructured":"Wadsworth JD, Asante EA, Desbruslais M, Linehan JM, Joiner S, Gowland I, et al. Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science. 2004;306(5702):1793\u20136. doi: 10.1126\/science.1103932 .","journal-title":"Science"},{"issue":"7551","key":"143_CR89","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/bmj.38804.511644.55","volume":"332","author":"JW Ironside","year":"2006","unstructured":"Ironside JW, Bishop MT, Connolly K, Hegazy D, Lowrie S, Le Grice M, et al. Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. BMJ. 2006;332(7551):1186\u20138. doi: 10.1136\/bmj.38804.511644.55 .","journal-title":"BMJ"},{"issue":"7551","key":"143_CR90","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1136\/bmj.332.7551.1164","volume":"332","author":"K Wilson","year":"2006","unstructured":"Wilson K, Ricketts MN. A new human genotype prone to variant Creutzfeldt-Jakob disease. BMJ. 2006;332(7551):1164\u20135. doi: 10.1136\/bmj.332.7551.1164 .","journal-title":"BMJ"},{"key":"143_CR91","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1471-2350-10-146","volume":"10","author":"MT Bishop","year":"2009","unstructured":"Bishop MT, Pennington C, Heath CA, Will RG, Knight RS. PRNP variation in UK sporadic and variant Creutzfeldt Jakob disease highlights genetic risk factors and a novel non-synonymous polymorphism. BMC Med Genet. 2009;10:146. doi: 10.1186\/1471-2350-10-146 .","journal-title":"BMC Med Genet"},{"issue":"9707","key":"143_CR92","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(09)61568-3","volume":"374","author":"D Kaski","year":"2009","unstructured":"Kaski D, Mead S, Hyare H, Cooper S, Jampana R, Overell J, et al. Variant CJD in an individual heterozygous for PRNP codon 129. Lancet. 2009;374(9707):2128. doi: 10.1016\/S0140-6736(09)61568-3 .","journal-title":"Lancet"},{"key":"143_CR93","doi-asserted-by":"crossref","first-page":"f5675","DOI":"10.1136\/bmj.f5675","volume":"347","author":"ON Gill","year":"2013","unstructured":"Gill ON, Spencer Y, Richard-Loendt A, Kelly C, Dabaghian R, Boyes L, et al. Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ. 2013;347:f5675. doi: 10.1136\/bmj.f5675 .","journal-title":"BMJ"},{"key":"143_CR94","unstructured":"Network C-JDIS. Creutzfeldt-Jakob Disease International Surveillance Network [Accessed in January 2016] Available from: http:\/\/www.eurocjd.ed.ac.uk\/index.html ."},{"key":"143_CR95","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2807\/ese.17.15.20144-en","volume":"17","author":"E Alcalde-Cabero","year":"2012","unstructured":"Alcalde-Cabero E, Almazan-Isla J, Brandel JP, Breithaupt M, Catarino J, Collins S, et al. Health professions and risk of sporadic Creutzfeldt-Jakob disease, 1965 to 2010. Euro Surveill. 2012;17:15.","journal-title":"Euro Surveill"},{"issue":"10","key":"143_CR96","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1007\/s00415-009-5163-x","volume":"256","author":"A Ladogana","year":"2009","unstructured":"Ladogana A, Sanchez-Juan P, Mitrova E, Green A, Cuadrado-Corrales N, Sanchez-Valle R, et al. Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies. J Neurol. 2009;256(10):1620\u20138. doi: 10.1007\/s00415-009-5163-x .","journal-title":"J Neurol"},{"key":"143_CR97","unstructured":"(NPDPSC) NPDPSC. National Prion Disease Pathology Surveillance Center (NPDPSC). [Accessed in January 2016]. Available from: http:\/\/case.edu\/med\/pathology\/centers\/npdpsc\/\/index.html ."},{"key":"143_CR98","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1471-2377-11-133","volume":"11","author":"MB Coulthart","year":"2011","unstructured":"Coulthart MB, Jansen GH, Olsen E, Godal DL, Connolly T, Choi BC, et al. Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study. BMC Neurol. 2011;11:133. doi: 10.1186\/1471-2377-11-133 .","journal-title":"BMC Neurol"}],"container-title":["Infectious Diseases of Poverty"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-016-0143-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:27:51Z","timestamp":1655771271000},"score":1,"resource":{"primary":{"URL":"http:\/\/idpjournal.biomedcentral.com\/articles\/10.1186\/s40249-016-0143-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,2]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["143"],"URL":"https:\/\/doi.org\/10.1186\/s40249-016-0143-8","relation":{},"ISSN":["2049-9957"],"issn-type":[{"value":"2049-9957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,2]]},"article-number":"47"}}